Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
11/2009
11/24/2009CA2385859C 2'-substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them
11/19/2009US20090286841 Certain chemical entities, compositions, and methods
11/19/2009US20090286828 2-amino-1-phenylethylcarboxamide derivatives
11/18/2009EP1858836B1 Analogues of the azinomycins as anti-tumour agents and as prodrugs
11/18/2009CN101580479A Method for reducing impurities in atorvastatin midbody
11/18/2009CN101580478A Method for synthesizing three direction dendrimer core by microwave
11/17/2009US7618981 Imidazopyridinyl-benzamide anti-cancer agents
11/12/2009WO2009137412A1 Therapeutic compounds
11/12/2009WO2009136409A2 Hydrogenation of imines
11/12/2009WO2009135590A1 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
11/12/2009CA2723302A1 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
11/11/2009EP2116526A1 Derivates of substituted tartaric aicd and usage for preparating beta secretase inhibitors
11/11/2009EP2114862A1 Process for the preparation of o-desmethyl venlafaxine
11/11/2009EP1742908B1 Non-nucleoside reverse transcriptase inhibitors
11/11/2009EP1713823B1 Hcv ns-3 serine protease inhibitors
11/11/2009EP1372634B1 Use of fumaric acid amides
11/11/2009EP1255726B1 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/11/2009CN100558697C Cycloalkyl inhibitors of potassium channel function
11/05/2009WO2009133181A1 Ether-amide type compounds, preparation method and uses
11/05/2009WO2009132979A1 4-trimethylammonio-butyrates as cpt2 inhibitors
11/05/2009WO2009132978A1 4-dimethylaminobutyric acid derivatives
11/05/2009WO2008075040A3 Radioactive pet agents for imaging ccr5 in vivo
11/05/2009US20090275758 Process for phenylacetic acid derivatives
11/05/2009CA2723004A1 Ether-amide type compounds, preparation method and uses
11/05/2009CA2722114A1 4-trimethylammonio-butyrates as cpt2 inhibitors
11/05/2009CA2722087A1 4-dimethylaminobutyric acid derivatives
11/04/2009EP1817296B1 Potentiators of glutamate receptors
11/04/2009EP1784388B1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
11/04/2009EP1216226B1 Process for phenylacetic acid derivatives
11/03/2009US7612054 Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
11/03/2009CA2565660C Ortho substituted aryl or heteroaryl amide compounds
10/2009
10/29/2009WO2009110942A3 Generation of combinatorial synthetic libraries and screening for novel proadhesins and nonadhesins
10/29/2009US20090270423 Antibacterial small molecules and methods for their synthesis
10/29/2009US20090270338 Diaryl-cyclylalkyl derivatives as calcium channel blockers
10/28/2009EP2111399A2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
10/28/2009EP2111223A1 Amine derivative compounds for treating ophthalmic diseases and disorders
10/28/2009CN100554244C New mao-b inhibitors
10/27/2009US7608731 Phenylacetic acid compounds
10/27/2009US7608590 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV)
10/27/2009CA2536870C Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists
10/27/2009CA2432713C Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
10/22/2009WO2009129395A1 Cationic lipids and uses thereof
10/22/2009WO2009129387A2 Cationic lipids and uses thereof
10/22/2009WO2009129385A1 Cationic lipids and uses thereof
10/22/2009WO2009127560A1 Intermediates for the preparation of pregabalin and process for their preparation
10/21/2009EP2110372A1 Intermediates for the preparation of Pregabalin and process for their preparation
10/21/2009EP1567478B1 Method of producing nitrile compounds from ethylenically-unsaturated compounds
10/21/2009EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
10/21/2009CN101560170A Method for preparing 5-(bromoacetyl) salicylamide
10/20/2009US7605176 β-ketoamide compounds with MCH antagonistic activity
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/15/2009WO2009125191A1 Benzene derivatives
10/15/2009WO2009124853A1 New ruthenium complexes as catalysts for metathesis reactions
10/15/2009US20090258884 Substituted amides
10/15/2009CA2719531A1 New ruthenium complexes as catalysts for metathesis reactions
10/14/2009EP1718582B1 Method for selective reduction of aromatic compounds
10/14/2009EP1390343B1 Novel retinoid derivatives and an anti-cancer pharmaceutical composition comprising said compounds
10/14/2009CN101558035A Preparation of 3,4-dihydroisoquinolines from an acid and an amine
10/14/2009CN101555213A Preparation method of N-(phenelyl)-2-hydroxybenzamide
10/14/2009CN101555212A Synthesized micromolecule compound capable of conveying bioactivator and application thereof
10/13/2009US7601872 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell
10/13/2009US7601674 α-oxygenated or α-thiolated carboxylic acid phenethylamide derivatives
10/08/2009WO2009124022A1 2 -aminotetralin derivatives as mu opioid receptor antagonists
10/08/2009WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009WO2009121490A1 Continuous method for producing amides of low aliphatic carboxylic acids
10/08/2009WO2009121489A1 Continuous method for producing amides of aliphatic hydroxy carboxylic acids
10/08/2009WO2009121484A1 Continuous method for producing amides of aromatic carboxylic acids
10/08/2009US20090253811 Manufacture process of organic compounds
10/08/2009US20090253787 Short-acting sedative hypnotic agents for anesthesia and sedation
10/08/2009US20090253659 Cycloalkylidene Compounds As Modulators of Estrogen Receptor
10/08/2009US20090253166 Conjugation of Peptides
10/08/2009DE102008017213A1 Kontinuierliches Verfahren zur Herstellung von Amiden aliphatischer Hydroxycarbonsäuren A continuous process for the preparation of amides of aliphatic hydroxycarboxylic acids
10/08/2009CA2720370A1 Continuous method for producing amides of low aliphatic carboxylic acids
10/08/2009CA2720347A1 Continuous method for producing amides of aliphatic hydroxycarboxylic acids
10/08/2009CA2720319A1 Continuous method for producing amides of aromatic carboxylic acids
10/07/2009EP0741700B1 1-h-3-arylpyrrolidine-2,4-dione derivatives as pest-control agents
10/07/2009CN101553493A Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity
10/07/2009CN100546974C Method for extracting coronatine
10/06/2009US7598412 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators
10/06/2009US7598242 Compounds for the treatment of inflammatory disorders
10/06/2009CA2301377C N-aroylphenylalanine derivatives
10/01/2009WO2009119858A1 Benzene compound, and use thereof for medical purposes
10/01/2009US20090247522 Hsp90 FAMILY PROTEIN INHIBITORS
09/2009
09/30/2009EP1745011B1 Modulators of cannabinoid receptors
09/30/2009CN101544579A Use and preparation method of 4-(-2-acetoxybenzoyl)aminobutyric acid and ester derivative thereof
09/29/2009US7595399 Tyrosine derivatives
09/29/2009US7595345 side effect reduction; bone disease and psoriasis; compounds display the desirable cell differentiation and antiproliferative effects with reduced calcium mobilization; 2-(4-{1-Ethyl-1-[4-(1-hydroxy-cyclopentylethynyl)-3-methyl-phenyl]-propyl}-2-methyl-benzoylamino)-2-methyl-propionic acid
09/29/2009US7595343 Inhibitors of histone deacetylase
09/29/2009US7595341 Analogues of lipid mediators derived from ω-3 PUFAs and methods of use
09/29/2009CA2550372C Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
09/29/2009CA2469882C Novel stable crystals of substituted phenylpropionic acid derivative and process for producing the same
09/24/2009US20090239866 Peptide deformylase inhibitors
09/24/2009US20090239832 Drugs for chronic pain
09/24/2009US20090239811 Polycationic compounds and uses thereof
09/24/2009US20090238882 Carbon-substituted diketopiperazine delivery systems
09/23/2009EP2101751A1 Benzamide derivatives as ep4 receptor agonists
09/23/2009CN101541743A Transdermal delivery systems of peptides and related compounds
09/23/2009CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
09/23/2009CN101538200A Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants
09/22/2009US7592478 Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 157